| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10907429 | Experimental Hematology | 2011 | 13 Pages |
Abstract
Our data suggest that Bcl-2 is a better therapeutic target than c-Myc, but attacking both Bcl-2 and c-Myc would be an even more effective treatment strategy for diffuse large B-cell lymphomas with concurrent Bcl-2 and c-Myc overexpression.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Nana Sasaki, Junya Kuroda, Hisao Nagoshi, Mio Yamamoto, Satoru Kobayashi, Yasuhiko Tsutsumi, Tsutomu Kobayashi, Yuji Shimura, Yosuke Matsumoto, Tomohiko Taki, Kazuhiro Nishida, Shigeo Horiike, Yukihiro Akao, Masafumi Taniwaki,